Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03387020 · MORE INFO

Limitations, agreements, and source contact

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors · Source last updated 2021-08-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Investigator Initiated Interventional Trial Agreement between Novartis and PBTC and Cincinnati Children's Hospital Medical Center.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
arzu.onar@stjude.org
organization
St. Jude Children's Research Hospital
phone
901-595-5499
title
Dr. Arzu Onar-Thomas
Complete source fields
certain Agreement
other Details
Investigator Initiated Interventional Trial Agreement between Novartis and PBTC and Cincinnati Children's Hospital Medical Center.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
arzu.onar@stjude.org
organization
St. Jude Children's Research Hospital
phone
901-595-5499
title
Dr. Arzu Onar-Thomas

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice